are there ever any cases in which cancer has an effect on the podiatric health of a patient? in other words, can a cancer patient present any variables due to his/her cancerous condition that would cause or force a podiatrist to take a different route as far as treatment is concerned?
In so many ways.
Phramacologic:
Some chemotherapeutic drugs may be metabolized by one of the many cytochrome p450 subfamilies thus affecting the systemic and therapeutic levels of both drugs.
Cancers may disrupt normal absorption, distribution, metabolism and excretion of chemotherapeutic agents depending on the drug and the particulars of the cancer.
For example, if the patient has liver or kidney dysfunction related to his or her cancer and/or the treatment, certain medications may not be able to be cleared as efficiently from the body and dose monitoring may be necessary. Again, knowing how the drug is metabolized and excreted may be beneficial in determining the appropriate clinical selection of therapy.
Similarly, removal of organs and tissues b/c of malignant growth may impede absorption, distribution, metabolism and excretion of chemotherapeutic agents.
There are many considerations that could be discussed regarding the phramacological aspects of treating pts.
Physicologically:
The neoproliferative state of the malignancy may exact excessive nutrient requirements that the patient can't fufil due to cancer cachexia, or sheer tumor load and the subsequent nutritional demand leading to a shift in the metabolic state of the pt with the patient becoming acidotic due to the shift to reliance on fatty acids for energy. (which may impact some therapies and even the types of organisms that can grow in the blood as in a septicemia or may shift the pka of particular functional groups on the drug and change affinity for the binding site) This may also relate to the pharmacologic transport of these metabolites and reduce the available bilirubin for chemotherapeutic modalities to be effectively stored and transported. For example, if a drug has a high affinity for protein binding to be transported in the blood, it may require different dosing in order to compensated for the decreased available protein available for binding.
Again, this doesn't even scratch the surface of how important our basic sciences are.
This discussion could get into everything from psychosocial aspects ( does a cancer pt want a particular therapy if they only have X amount of months to live) to immunological (cytokines and immune fxn), metastatic spread, hemodynamics etc, etc..... But I have 30000 other things I should be doing right now.
I think that any disease could potentially have implications on our podiatric practice of medicine and we all need to be well aware of that.
The foot and ankle are very well attached to the rest of the body;
in more ways than one.